XIth Eurasian Hematology-Oncology Congress - EHOC 2020
Decision Making in R/R MM: What Options to Consider for 1st Relapse in Disease not Refractory to Lenalidomide, First Relapse in Lenalidomide-Refractory Disease, or After 2+ Prior Therapies?
Comments 0
Login to view comments.
Click here to Login
